>>DB1976

DB1976

Catalog No.GC39627

DB1976은 DB270의 셀레노펜 유사체이며 강력하고 세포 투과성이 있으며 완전히 효과적인 전사 인자 PU.1 억제제입니다. DB1976은 시험관 내에서 PU.1 결합(IC50 10nM)을 강력하게 억제하고 PU.1/DNA 복합체(높은 DB1976-ΛB 친화성, KD 12nM)를 강력하게 억제합니다. DB1976은 세포사멸을 유도하는 효과가 있습니다.

Products are for research use only. Not for human use. We do not sell to patients.

DB1976 Chemical Structure

Cas No.: 1557397-51-9

Size 가격 재고 수량
5mg
US$417.00
재고 있음
10mg
US$695.00
재고 있음
50mg
US$1,947.00
재고 있음
100mg
US$2,735.00
재고 있음

Tel:(909) 407-4943 Email: sales@glpbio.com

고객 리뷰

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Product has been cited by 1 publications

Description Chemical Properties Product Documents Related Products

DB1976 is a selenophene analog of DB270 and a potent and cell-permeable fully efficacious transcription factor PU.1 inhibitor. DB1976 potently inhibits PU.1 binding (IC50 of 10 nM) and strongly inhibits the PU.1/DNA complex (with high DB1976-ΛB affinity, KD of 12 nM) in vitro. DB1976 has apoptosis-inducing effect[1][2][3].

[1]. Munde M, et al. Structure-dependent inhibition of the ETS-family transcription factor PU.1 by novel heterocyclic diamidines. Nucleic Acids Res. 2014 Jan;42(2):1379-90. [2]. Stephens DC, et al. Pharmacologic efficacy of PU.1 inhibition by heterocyclic dications: a mechanistic analysis. Nucleic Acids Res. 2016 May 19;44(9):4005-13. [3]. Antony-DebrÉ I, et al. Pharmacological inhibition of the transcription factor PU.1 in leukemia. J Clin Invest. 2017 Dec 1;127(12):4297-4313.

리뷰

Review for DB1976

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for DB1976

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.